GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Monash IVF Group Ltd (ASX:MVF) » Definitions » Gross Profit

Monash IVF Group (ASX:MVF) Gross Profit : A$211.2 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Monash IVF Group Gross Profit?

Monash IVF Group's gross profit for the six months ended in Dec. 2023 was A$112.0 Mil. Monash IVF Group's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was A$211.2 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Monash IVF Group's gross profit for the six months ended in Dec. 2023 was A$112.0 Mil. Monash IVF Group's Revenue for the six months ended in Dec. 2023 was A$125.7 Mil. Therefore, Monash IVF Group's Gross Margin % for the quarter that ended in Dec. 2023 was 89.11%.

Monash IVF Group had a gross margin of 89.11% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 10 years, the highest Gross Margin % of Monash IVF Group was 91.59%. The lowest was 88.72%. And the median was 89.74%.


Monash IVF Group Gross Profit Historical Data

The historical data trend for Monash IVF Group's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monash IVF Group Gross Profit Chart

Monash IVF Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 136.43 129.01 163.71 172.51 191.19

Monash IVF Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.98 81.53 91.97 99.22 112.02

Competitive Comparison of Monash IVF Group's Gross Profit

For the Diagnostics & Research subindustry, Monash IVF Group's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Monash IVF Group's Gross Profit Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Monash IVF Group's Gross Profit distribution charts can be found below:

* The bar in red indicates where Monash IVF Group's Gross Profit falls into.



Monash IVF Group Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Monash IVF Group's Gross Profit for the fiscal year that ended in Jun. 2023 is calculated as

Gross Profit (A: Jun. 2023 )=Revenue - Cost of Goods Sold
=213.59 - 22.399
=191.2

Monash IVF Group's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=125.704 - 13.688
=112.0

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$211.2 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Monash IVF Group's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=112.0 / 125.704
=89.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Monash IVF Group  (ASX:MVF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Monash IVF Group had a gross margin of 89.11% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Monash IVF Group Gross Profit Related Terms

Thank you for viewing the detailed overview of Monash IVF Group's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Monash IVF Group (ASX:MVF) Business Description

Traded in Other Exchanges
Address
510 Church Street, Level 1, Cremorne, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is a specialist assisted reproductive services provider. The company offers specialist diagnostic obstetric and gynaecological ultrasound and fertility treatments. The company's operating segment includes Australia and International. It generates maximum revenue from the Australian segment. Australian segment is a provider of Assisted Reproductive Services, Ultrasound, and other related services. The International segment is a provider of Assisted Reproductive Services in Malaysia.